Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for SIGA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 1997. Start Trial.
Date Value
July 31, 2026 82.88%
June 30, 2026 82.20%
May 31, 2026 82.20%
April 30, 2026 82.20%
March 31, 2026 82.20%
February 28, 2026 82.20%
January 31, 2026 82.20%
December 31, 2025 82.20%
November 30, 2025 82.20%
October 31, 2025 82.20%
September 30, 2025 82.20%
August 31, 2025 82.20%
July 31, 2025 82.20%
June 30, 2025 82.20%
May 31, 2025 82.20%
April 30, 2025 82.20%
March 31, 2025 82.20%
February 28, 2025 82.20%
January 31, 2025 82.20%
December 31, 2024 82.20%
November 30, 2024 82.20%
October 31, 2024 82.20%
September 30, 2024 82.20%
August 31, 2024 82.20%
July 31, 2024 82.20%
Date Value
June 30, 2024 82.20%
May 31, 2024 82.20%
April 30, 2024 82.20%
March 31, 2024 82.20%
February 29, 2024 82.20%
January 31, 2024 82.20%
December 31, 2023 82.20%
November 30, 2023 82.20%
October 31, 2023 82.20%
September 30, 2023 82.20%
August 31, 2023 81.09%
July 31, 2023 80.18%
June 30, 2023 80.00%
May 31, 2023 80.00%
April 30, 2023 80.00%
March 31, 2023 80.00%
February 28, 2023 74.57%
January 31, 2023 73.12%
December 31, 2022 72.12%
November 30, 2022 68.37%
October 31, 2022 66.42%
September 30, 2022 61.68%
August 31, 2022 52.16%
July 31, 2022 52.16%
June 30, 2022 52.16%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 72.96%
Corcept Therapeutics, Inc. 71.85%
Veru, Inc. 99.12%
Johnson & Johnson 18.44%
Eli Lilly & Co. 34.47%